Teva 'Plagued By Problems,' Downgraded On Lost MS Drug Patents, DOJ Probe | Stock News & Stock Market Analysis - IBD
Jury finds Teva Pharmaceuticals fueled opioid epidemic in New York State
Teva Pays $420 Million to End Generic-Drug Securities Suit (1)
Teva Pharm expects to start paying U.S. opioid settlement in 2023 - CEO
Teva Pharmaceutical Industries' new CEO Jeremy Levin speaks during a news conference in Tel Aviv May 9, 2012. Teva Pharmaceutical Industries posted a 40 percent jump in quarterly profit that beat estimates,
New York AG: Teva USA's parent company shouldn't be allowed to escape opioid liability - MedCity News
Teva CEO Sees a Final Opioid Settlement Coming This Year | Barron's
Teva shares surge after announcing global opioid settlement
Teva Pharmaceuticals CEO on the Covid-19 vaccine rollout in Israel - YouTube
Teva Tries to Put an End to the Opioid Wars - WSJ
Teva sees return to growth after opioid settlement, shares jump | Reuters
Teva bought the pharm, and now it may have bought the farm | The Times of Israel
Teva Pharmaceutical Industries (TEVA) Stock Price, News & Info | The Motley Fool
TEVA Plunges on Q1 Results - TipRanks.com
Teva CEO Schultz likely won't renew employment contract: reports
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Teva made smart decision to move to us: Allergan CEO
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
Why are investors so pleased about Teva's $4.35 billion opioid settlement? | Ctech
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva's Richard Francis launches 'pivot to growth' strategy | Fox Business Video
teva News and latest stories | The Jerusalem Post
